Hoth Therapeutics 和 Acurx Pharmaceuticals 各向比特币分配 100 万美元，反映出人们对加密货币作为金融资产的兴趣日益浓厚

Hoth Therapeutics 是一家临床阶段的生物制药公司，将向比特币分配 100 万美元，理由是比特币具有对冲通胀和价值储存的潜力。

Two publicly traded pharmaceutical companies, Hoth Therapeutics and Acurx Pharmaceuticals, have each announced plans to allocate up to $1 million to Bitcoin as part of their treasury strategies.

两家上市制药公司 Hoth Therapeutics 和 Acurx Pharmaceuticals 均宣布计划向比特币分配最多 100 万美元，作为其财务策略的一部分。

Hoth Therapeutics, a clinical-stage biopharmaceutical company, will be adding Bitcoin to its treasury, specifically allocating $1 million. The move is part of a broader trend of Bitcoin adoption by businesses, with the company citing the cryptocurrency’s potential as a hedge against inflation and a store of value.

Hoth Therapeutics 是一家临床阶段的生物制药公司，将在其资金库中添加比特币，具体分配 100 万美元。此举是企业采用比特币的更广泛趋势的一部分，该公司指出加密货币具有对冲通胀和价值储存的潜力。

The company’s board of directors approved the move, which is influenced by several factors including the approval of exchange-traded funds (ETFs) and increased market activity.

该公司董事会批准了这一举措，这是受到交易所交易基金（ETF）批准和市场活动增加等多种因素影响的。

“The approval of bitcoin ETFs and the trust of major financial institutions in this asset class, combined with the observed strength of bitcoin as an inflation hedge and store of value over the last several months, have influenced our decision,” said Robb Knie, CEO of Hoth, in a statement.

首席执行官 Robb Knie 表示：“比特币 ETF 的批准和主要金融机构对这一资产类别的信任，再加上过去几个月观察到的比特币作为通胀对冲和保值手段的实力，影响了我们的决定。”霍斯在一份声明中表示。

Hoth’s treasury strategy is focused on preserving capital and generating a return on cash not needed for operations over the next 12 to 18 months. The company’s drug development plans will not be affected by this decision.

霍斯的财务策略侧重于保存资本并产生未来 12 至 18 个月运营不需要的现金回报。公司的药物开发计划不会受到该决定的影响。

“We believe that bitcoin will serve as a strong treasury reserve asset,” said David P. Luci, CEO of Acurx, in a statement.

Acurx 首席执行官 David P. Luci 在一份声明中表示：“我们相信比特币将成为一种强大的国库储备资产。”

The company’s financial strategy is centered on deploying cash efficiently and includes a preference for inflation-resistant investments.

该公司的财务战略以有效配置现金为中心，并优先考虑抗通胀投资。

“We believe bitcoin to be an optimal treasury reserve asset. It is a scarce digital asset with a limited supply of 21 million bitcoin ever to be created, rendering it inherently inflation resistant,” Luci added.

“我们相信比特币是最佳的国库储备资产。它是一种稀缺的数字资产，比特币的发行量有限，为 2100 万枚，因此具有固有的抗通胀能力。”Luci 补充道。